Mohsen Tehrani - Immunobiochemistry lab, Immunology Research Center, Bu-Ali Research Institute, Mashhad, Iran
Abdol-Reza Varasteh - Immunobiochemistry lab, Immunology Research Center, Bu-Ali Research Institute, Mashhad, Iran
Mohammad Reza Khakzad - Zakaria Research Center, Azad University of Mashhad, Mashhad, Iran
Majid Mirsadraee - Zakaria Research Center, Azad University of Mashhad, Mashhad, Iran
Mojtaba Sankian - Immunobiochemistry lab, Immunology Research Center, Bu-Ali Research Institute, Mashhad, Iran

Background: Recently, reports have indicated a role for the membrane form of Toll-like Receptor ۲ (TLR۲) in asthma pathogenesis. In this study we examined soluble TLR۲ levels in serum and sputum of asthmatic and healthy subjects. Methods: Serum and sputum samples were obtained from ۳۳ asthmatic and ۱۹ healthy subjects. The asthmatics were classified into four groups according to the Global Initiative for Asthma. A sandwich ELISA was developed to measure soluble TLR۲ (sTLR۲) in serum and sputum. TLR۲ mRNA expression was determined by semi-quantitative RT-PCR of all sputum samples. Results: The mean sTLR۲ levels from serum and sputum of asthmatics were significantly lower than those from healthy subjects. Moreover, sTLR۲ concentration decreased concomitantly with asthma severity. The differences observed, however, were not statistically significant. TLR۲/GAPDH mRNA of sputum leukocytes was also significantly lower in asthmatics than in healthy subjects. Conclusion: This study demonstrated for the first time thatsTLR۲ levels are lower in serum and sputum samples from asthmatic than from healthy subjects, and this could be an indicator of TLR۲ expression. We also found that sTLR۲ concentration in serum decreased concomitantly with an increase of asthma severity clinical score.

Asthma, Expression, Soluble Toll-like receptor, TLR۲ mRNA